Skip to content

the efficace of magnesium sulfate in preterm labor pain managment

Comparision of maintenance therapy and continuous intravenous therapy with magnesium sulfate in preterm labor pain management at 24-36 weeks gestation: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013112913932N2
Enrollment
70
Registered
2013-12-14
Start date
2013-03-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

preterm labour pain. Preterm spontaneous labour with preterm delivery

Interventions

Intervention 1: The patients in group A, will be received 4gr magnesium sulfate in 200cc D/W 5% during 15 to 20 minutes and then infusion of 20 gr magnesium sulfate during 10 hours (2gr/h). Interven
Treatment - Drugs
The patients in group A, will be received 4gr magnesium sulfate in 200cc D/W 5% during 15 to 20 minutes and then infusion of 20 gr magnesium sulfate during 10 hours (2gr/h)
The patients in group B, will be received 4gr magnesium sulfate in 200cc D/W 5% during 15 to 20 minutes and then continues infusion of 2gr/hr magnesium sulfate for 12 hours

Sponsors

Hormozgan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Inclusion criteria:gestational age of 24 - 36 weeks;the presence of atleast 4 uterus contraction during 20 min; dilatation below 4 cm; effacement less than 80% Exclusion criteria:coexistense of medical disease such as diabetes mellitus; asthma; cardiovascular disease; preeclampsia; uterine bleeding; rupture of membrane; placenta decolman; intruterine infections; UTI; fetus anomalies; previous preterm labor pain; lack of decreasing uterus contractions during 2 first hr after administration of magnesium sulfate; The patient need to administration of magnesium sulfate after 24 h.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Controlling uterine contraction. Timepoint: during intervention- 24 h after intervention. Method of measurement: checking uterine contraction by hand.;Preterm delivery. Timepoint: just after intervention- 48 h after intervention. Method of measurement: , delivery before 37 weeks of gestation.

Secondary

MeasureTime frame
Duration of pregnancy. Timepoint: during and after intervention. Method of measurement: day.;Duration of neonatal admission in NICU. Timepoint: after intervention. Method of measurement: day.

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026